Sign up to see all 5.
Sign up to see all 5.
Sign up to see all 5.
Every notice on Red Flags →A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
F
FMR LLC
|
5.1M | 9.26% | +2.2M (+77.1%) | Q4 '25 | 0.0% | |
|
Shares held by quarter
Peak holding5.1M (Q2'26)
Change over 8 quarters+5.1M
Share of the company9.260%
|
||||||
|
B
BlackRock, Inc.
|
4.4M | 7.93% | +4.0M (+1234.7%) | 2023 | 0.0% | |
|
Shares held by quarter
Peak holding4.4M (Q2'26)
Change over 8 quarters+4.4M
Share of the company7.930%
|
||||||
28 more super investors behind a free account
See every manager holding Avalo Therapeutics, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
SS
SPDR Series Trust
|
$37.5M | 2.0M | 3.69% | 0.35% | June 30, 2026 |
|
VT
Vanguard Index Funds
|
$31M | 1.7M | 3.04% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Avalo Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
NG
Neil Garry Arthur
Insider
|
190.3K | 0.35% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company0.350%
|
||||||
|
DM
Doyle Mittie
Insider
|
51.8K | 0.09% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company0.090%
|
||||||
9 more holders behind a free account
See every insider and 5%+ holder of Avalo Therapeutics, Inc..
Sign up freeLoading...